NYU Study Identifies DNA Replication Issues Affecting PARP Inhibitor Response
A study led by researchers at NYU Langone Health’s Perlmutter Cancer Center identifies specific DNA…
Newswire
Pharmaceutical Group Spent $59 Million on Search Ads
The lobbying group for the U.S. pharmaceutical industry spent an estimated $59 million on search…
Boehringer Ingelheim Inks Up-to-$7.4B Cancer Drug Collaboration with Sino Biopharmaceutical
Boehringer Ingelheim has launched an up-to-$7.358 billion-plus collaboration with Sino Biopharmaceutical (SBP Group) to develop…
AI-Developed Bird Flu Vaccine Shows Complete Protection in Trials
Researchers at the University of Cambridge and DIOSynVax developed a broad-spectrum bird flu vaccine, DVX-panH5Nx,…
Novartis Reports Tumors Possibly Linked to Zolgensma Treatment
Novartis has acknowledged seven previously unknown instances of tumors found in children treated with its…
Orphan Therapeutics Accelerator In-Licenses OTXL-101 for OTCD
Orphan Therapeutics Accelerator (OTXL) has in-licensed an investigational therapy program for ornithine transcarbamylase deficiency (OTCD),…
Shilpa CDMO Invests $50 Million to Expand Peptide Manufacturing Capacity
Shilpa CDMO is committing $50 million to expand its peptide manufacturing infrastructure in India. The…
Emvena Therapeutics Launches to Develop Preeclampsia Treatment
Emvena Therapeutics has emerged from stealth with backing from the Penn-BioNTech Innovative Therapeutics Seed Fund…
T-Therapeutics Secures $133M for Bispecifics Development
T-Therapeutics has secured $133 million in a funding round aimed at advancing its bispecific antibody…
Phillips Medisize Expands UK Inhalation Operations with Chippenham Acquisition
Phillips Medisize is expanding its inhalation drug delivery capabilities in the UK after acquiring the…